Page 4 - Dabur

Burmans write to Sebi seeking probe into Religare share sale by chairperson

The Burman family has written to the Securities and Exchange Board of India, seeking a probe into trades in the shares of the Religare Enterprises Ltd by chairperson Rashmi Saluja

Dabur Q2 result: Profit up 5% to Rs 507.04 cr, revenue at Rs 3,203 cr

Homegrown FMCG major Dabur India Ltd on Thursday reported a 5 per cent increase in consolidated net profit at Rs 507.04 crore in the second quarter ended September 30. The company had posted a net profit of Rs 490.86 crore in the July-September quarter a year ago, according to a regulatory filing. Its revenue from operations was at Rs 3,203.84 crore in the quarter under review as against Rs 2,986.49 crore in the corresponding quarter of the previous fiscal. The company's expenses were at Rs 2,669.43 crore in the September quarter. Shares of Dabur India Ltd rose 2.18 per cent to Rs 528.40 apiece in afternoon trade on the BSE.

Stocks to Watch today: Bajaj Auto, Wipro, RIL, Dabur, IndusInd, Bandhan Bk

Stocks to watch on Thursday, October 19, 2023: FMCG majors ITC, Hindustan Unilever and Nestle also likely to be in focus ahead of Q2 results today.

FMCG major Dabur's three foreign subsidiaries face cases in US, Canada

Homegrown FMCG major Dabur on Wednesday said its three foreign subsidiaries are facing cases in federal and state courts in the US and Canada. The three Dabur India subsidiaries facing cases are Namaste Laboratories LLC, Dermoviva Skin Essentials Inc. and Dabur International Ltd, according to a regulatory filing. As per the filing, certain consumers in the hair relaxer product industry have alleged that some industry players/defendants sold and/or manufactured hair relaxer products that contain certain chemicals and that the use of the hair relaxer product has caused ovarian cancer, uterine cancer and other health issues. "Cases have been filed in both federal and state courts in the United States and Canada. The federal cases were consolidated as a Multi-District Litigation, also referred to as MDL, before the United States District Court for the Northern District of Illinois," it said. Currently, there are approximately 5,400 cases in the MDL, which named Namaste, Dermoviva and .

Dabur receives Rs 320 crore GST demand; company to challenge notice

The company intends to challenge the notice based on 'strong merits' in front of the relevant authorities and has ensured this does not impact the overall financials or operations going forward

Dabur receives GST demand notice of Rs 320.60 cr, firm to challenge matter

Homegrown FMCG and Ayurvedic products maker Dabur on Tuesday said it has received a Goods and Service Tax (GST) demand notice of Rs 320.60 crore. The company will challenge the same based on strong merits by filing its reply before the relevant authorities, Dabur India said in a regulatory filing. "The Company has received intimation of tax ascertained as being payable under Section 74(5) of CGST Act, 2017, wherein GST short paid / not paid amounting to Rs 320.60 crore has been advised to be paid by the Company along with the amount of applicable interest and penalty... failing which Show Cause Notice will be issued," Dabur informed. However, the company -- which owns power brands like Dabur Chyawanprash, Dabur Honey, Dabur Honitus, Dabur PudinHara, and Dabur Lal Tail -- said it will have "no impact on the financial, operation or other activities of the company. "The impact will be limited to the extent of final tax liability as may be ascertained along with interest and penalty, i

FMCG consumption showing improvement, gradually recovering: Dabur India

Helped by encouraging macro indicators, FMCG consumption is showing improvement year-on-year, though the recovery has been gradual, Dabur India said in its quarter updates. This quarter witnessed a mild summer and a slightly deficient monsoon. The festive season is later than normal this year due to which offtake related to festivals is delayed and will carry forward to the next quarter, it said. "We expect recovery of consumption in both urban and rural markets in India due to improving macro indicators, increase in government expenditure and positive consumer sentiment," Dabur said. The homegrown FMCG major expects a "mid to high single-digit growth" in its consolidated revenue during the July-September quarter. "In India business, Healthcare and HPC segments are expected to grow in high single-digit," it said in an update for the quarter ending on September 30, 2023. However, it anticipates the F&B business to remain "slightly below last year's revenue" on account of a mild ...

Dabur flags weak Q2 operating profit on delayed monsoon, festive season

Dabur, which sells Vatika Shampoo and Honitus cough syrup brands, said improving macro economic indicators and positive consumer sentiment will help in "gradual" recovery in urban and rural markets

We are now trying to reinvent Dabur as Dabur 2.0: CEO Mohit Malhotra

The brands being repackaged include the Rs 1,000 crore - Rs 1,500 crore Dabur Amla hair oil and Vatika shampoo in the home and personal care category

Burmans seek control of Religare Enterprises, make open offer to buy 26%

The entities are now looking to acquire 90,042,541 shares at a face value of Rs 235 per share

Burmans seek to boost financial services play with control of Religare

The Burmans now want to "increase the family's stake and take control" of Religare, in a move that will pit them against other billionaire families in the same business

Burman family makes open offer to acquire 26% stake in Religare Enterprises

In August, the family acquired a 7.5 per cent stake in Religare Enterprises for Rs 534, taking its total stake to 21 per cent

Lower inflation's full impact likely from Q3: Dabur India's Mohit Malhotra

The home-grown fast-moving consumer goods major also anticipates a good festival season to aid its growth in the December quarter

Sensex, Nifty end lower dragged by HDFC Bank, RIL; PSU Bank index jumps 3%

Closing Bell on Monday, September 18: The S&P BSE Sensex fell 242 points to 67,597 levels, while the Nifty50 ended below the 20,150-mark at 20,133, lower by 59 points

Dabur scaling up Hajmola and Odomos to include them on its power brand list

Home-grown FMCG major Dabur is scaling up its digestive brand Hajmola and mosquito repellent brand Odomos, amplifying their reach to include them on the list of its power brands, CEO Mohit Malhotra said. Dabur's fast moving consumer goods (FMCG) portfolio currently includes nine distinct power brands -- eight in India and one in the overseas markets, which together account for 70 per cent of its total sales. Currently, Dabur's 75 per cent revenue comes from the domestic business. Its domestic business is concentrated in eight power brands -- Dabur Chyawanprash, Dabur Honey, Dabur Honitus, Dabur PudinHara, Dabur Lal Tail, Dabur Amla, Dabur Red Paste, Real. Vatika is Dabur's international power brand offering a range of personal care products for the global audience. Currently, Dabur has 17 brands that are above Rs 100 crore but lesser than Rs 500 crore in size, said Malhotra while addressing the investor meet last week. "We have 17 brands, which are in the range of Rs 100-500 crore

Dabur eyes Rs 5,000 crore sales from healthcare in around 5 years

Homegrown FMCG products maker Dabur India is targeting Rs 5,000 crore in sales from its healthcare segment and Rs 7,000 crore from home and personal care vertical in the next 5-7 years, the company said in an investor meeting on Friday. Both healthcare and home and personal care verticals, part of the consumer care business, are major contributors to Dabur's business. In FY23, together accounted for 56.2 per cent of the consolidated sales of Dabur, which was Rs 11,530 crore. Besides, the company expects demand for natural products like herbal and Ayurvedic to grow in line with increasing per capita income. The company will also have more premium products in the power brands as the number of upper-middle-class people would grow. Besides, consumption of Low Unit Packs (LUP) would also grow in the rural markets, said Dabur CEO Mohit Malhotra. "LUP penetration would grow in this country. Dabur as an organisation, should add more LUP for more penetration in rural. More premium products

Dabur India Q1FY24 results: Consolidated net profit up 3.5% to Rs 456 cr

The total income for Q1FY24 came in at Rs 3,240.25 crore, compared to Rs 2,922.98 crore year-on-year

Dabur soars 7%, nears 52-week high as Q1 results boasts of rural recovery

According to the management, with a little negative impact from beverage portfolio, mid-single volume growth should be possible in the near term in the India business

Dabur scouting for acquisition targets in D2C healthcare, personal care

Homegrown FMCG major Dabur India is looking for an acquisition in direct-to-consumer (D2C) space, particularly in healthcare and personal care, its Chief Executive Officer Mohit Malhotra said on Thursday. The acquisition will help Dabur to increase its play in the fast-growing premium segment and also to strengthen our urban play, Malhotra said in a post-results Investors' Conference Call. Besides, the company, which owns iconic brands such as Dabur Amla, Dabur Vatika, and juice brand Real, is increasing investments in branding and promotion as its margins are improving quarter on quarter amidst softening commodity prices. When asked about any D2C acquisition, Malhotra replied: "We continue to scouting on targets in the D2C space also, particularly in healthcare and personal care... We are looking for a brand that will shore up margin and not be dilutive." "If we come across a company which is synergistic with the healthcare space and personal care space, skincare Ayurvedic play, w

Sensex sinks 505 pts, Nifty gives up 19,350 amid global weakness; PSBs soar

Closing Bell on July 7, 2023: PowerGrid, IndusInd Bank, HUL, NTPC, Bajaj Finance, HCL tech, Tech M, L&T, Asian Paints, ICICI Bank, ITC, Kotak Bank, Infosys, and HDFC twins declined up to 3 per cent